| Preparation and cytotoxic evaluation of PGV-1 derivative, CCA-1.1, as a new curcumin analog with improved-physicochemical and pharmacological properties RY Utomo, F Wulandari, D Novitasari, B Lestari, RA Susidarti, RI Jenie, ... Advanced Pharmaceutical Bulletin 12 (3), 603, 2022 | 16 | 2022 |
| Curcumin-like structure (CCA-1.1) induces permanent mitotic arrest (Senescence) on Triple-negative breast cancer (TNBC) cells, 4T1 D Novitasari, RI Jenie, F Wulandari, RY Utomo, DDP Putri, J Kato, ... Research Journal of Pharmacy and Technology 14 (8), 4375-4382, 2021 | 15 | 2021 |
| New curcumin analog, CCA-1.1, synergistically improves the antiproliferative effect of doxorubicin against T47D breast cancer cells F Wulandari, D Novitasari, M Kirihata, J Kato, E Meiyanto Indonesian Journal of Pharmacy, 244-256, 2020 | 15 | 2020 |
| The growth suppression activity of diosmin and PGV-1 co-treatment on 4T1 breast cancer targets mitotic regulatory proteins H Musyayyadah, F Wulandari, AF Nangimi, AD Anggraeni, E Meiyanto Asian Pacific Journal of Cancer Prevention: APJCP 22 (9), 2929, 2021 | 13 | 2021 |
| Curcumin analogs, PGV-1 and CCA-1.1 exhibit anti-migratory effects and suppress MMP9 expression on WiDr cells F Wulandari, M Kirihata, JY Kato, E Meiyanto The Indonesian Biomedical Journal 13 (3), 271-80, 2021 | 12 | 2021 |
| The anti-migratory activity of a new curcumin analog, CCA-1.1, against T47D breast cancer cells. F WULANDARI, RY UTOMO, D NOVITASARI, M IKAWATI, M KIRIHATA, ... International Journal of Pharmaceutical Research (09752366) 13 (1), 2021 | 11 | 2021 |
| A new curcumin analog, CCA-1.1, induces cell cycle arrest and senescence toward ER-positive breast cancer cells. D NOVITASARI, F WULANDARI, RI JENIE, RY UTOMO, JUNYA KATO, ... International Journal of Pharmaceutical Research (09752366) 13 (1), 2021 | 11 | 2021 |
| Bioinformatic analysis of CCA-1.1, a novel curcumin analog, uncovers furthermost noticeable target genes in colon cancer F Wulandari, E Meiyanto, M Kirihata, A Hermawan Gene Reports 21, 100917, 2020 | 11 | 2020 |
| Synthesis of new boron containing compound (CCB-2) based on curcumin structure and its cytotoxic effect against cancer cells E Meiyanto, RA Susidarti, RI Jenie, RY Utomo, D Novitasari, F Wulandari, ... Journal of Applied Pharmaceutical Science 10 (2), 060-066, 2020 | 10 | 2020 |
| Bioinformatics analysis confirms the target protein underlying mitotic catastrophe of 4T1 cells under combinatorial treatment of PGV-1 and galangin NAF Hasbiyani, F Wulandari, EP Nugroho, A Hermawan, E Meiyanto Scientia Pharmaceutica 89 (3), 38, 2021 | 9 | 2021 |
| Piperine increases pentagamavunon-1 anti-cancer activity on 4T1 breast cancer through mitotic catastrophe mechanism and senescence with sharing targeting on mitotic regulatory … E Endah, F Wulandari, Y Putri, RI Jenie, E Meiyanto Iranian Journal of Pharmaceutical Research: IJPR 21 (1), 2022 | 8 | 2022 |
| The cytotoxic and anti-migratory properties of Caesalpinia sappan and Ficus septica, in combination with Doxorubicin on 4T1 TNBC cells with nephroprotective potential S Haryanti, UM Zulfin, IA Salsabila, F Wulandari, E Meiyanto Asian Pacific Journal of Cancer Prevention: APJCP 23 (2), 743, 2022 | 8 | 2022 |
| A new curcumin analog, CCA-1.1, induces cell death and cell cycle arrest in WiDr colon cancer cells via ROS generation F Wulandari, M Ikawati, M Kirihata, JY Kato, E Meiyanto Journal of Applied Pharmaceutical Science 11 (10), 099-105, 2021 | 8 | 2021 |
| Identification of potential targets of the curcumin analog CCA-1.1 for glioblastoma treatment: integrated computational analysis and in vitro study A Hermawan, F Wulandari, N Hanif, RY Utomo, RI Jenie, M Ikawati, ... Scientific Reports 12 (1), 13928, 2022 | 5 | 2022 |
| Synthesis and cytotoxicity of the boron carrier pentagamaboronon-0-ol for boron neutron capture therapy against breast cancer RY Utomo, F Wulandari, D Novitasari, RA Susidarti, M Kirihata, ... Journal of Advanced Pharmaceutical Technology & Research 13 (1), 70-76, 2022 | 4 | 2022 |
| PGV-1 permanently arrests HepG2 cells in M phase and inhibits liver carcinogenesis in DMH-induced rats D Novitasari, J Kato, DDP Putri, F Wulandari, S Widyarini, UM Zulfin, ... Journal of Applied Pharmaceutical Science 13 (8), 204-211, 2023 | 3 | 2023 |
| The Synergistic Effect of Combination of Pentagamavunone-1 with Diosmin, Galangin, and Piperine in WiDr Colon Cancer Cells: In vitro and Target Protein Prediction. M Ikawati, H Musyayyadah, YM Putri, UM Zulfin, F Wulandari, DDP Putri, ... Journal of Tropical Biodiversity & Biotechnology 8 (2), 2023 | 3 | 2023 |
| Tumour‐suppressive effects of curcumin analogs CCA‐1.1 and pentagamavunone‐1 in colon cancer: in vivo and in vitro studies F Wulandari, M Ikawati, S Widyarini, M Kirihata, D Novitasari, J Kato, ... Journal of Advanced Pharmaceutical Technology & Research 14 (4), 317-324, 2023 | 2 | 2023 |
| Integrative Bioinformatics Reveals the Lactate Dehydrogenase B (LDHB) Significance in Colon Adenocarcinoma F Wulandari, M Hanifa Molecular and Cellular Biomedical Sciences 7 (2), 98-108, 2023 | 2 | 2023 |
| The Two Mono-Carbonyl Curcumin Analogs, PGV-1 and CCA-1.1: The Chemopreventive Activity Against DMH-Induced Colorectal Cancer Rat and Proteins Target Candidate Involved F Wulandari, M Kirihata, S Widyarini, JY Kato, E Meiyanto | 1 | 2021 |
